Paper33465313
Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.
Blankenship CM and 8 others. Am J Audiol, 2021. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort. Papers, record 33465313. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33465313
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Speech Perception | Major topic |
| Adolescent | |
| Aminoglycosides | |
| Anti-Bacterial Agents | |
| Child | |
| Cross-Sectional Studies | |
| Hearing Loss, High-Frequency | |
| Humans | |
| Young Adult |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DC010202 | NIDCD NIH HHS | United States | R01DC010202 | PubMed | NIH RePORTER |
| UL1 TR001425 | NCATS NIH HHS | United States | UL1TR001425 | PubMed | NIH RePORTER |
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21234508 | Low prevalence of middle ear disease in cystic fibrosis patients. | J Pediatr (Rio J) | 2011 | https://conductscience.org/library/papers/21234508 | PubMed |
| 2 | 6487144 | Extended high-frequency hearing loss in children with cleft palate. | Audiology | 1984 | https://conductscience.org/library/papers/6487144 | PubMed |
| 4 | 26480907 | High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients. | Braz J Otorhinolaryngol | 2015 | https://conductscience.org/library/papers/26480907 | PubMed |
| 5 | 29800354 | Children's Speech Perception in Noise: Evidence for Dissociation From Language and Working Memory. | J Speech Lang Hear Res | 2018 | https://conductscience.org/library/papers/29800354 | PubMed |
| 6 | 5422338 | The hearing of patients with cystic fibrosis. | Arch Otolaryngol | 1970 | https://conductscience.org/library/papers/5422338 | PubMed |
| 7 | 28012509 | Changes in the inner ear structures in cystic fibrosis patients. | Int J Pediatr Otorhinolaryngol | 2017 | https://conductscience.org/library/papers/28012509 | PubMed |
| 8 | 18929686 | Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. | J Biomed Inform | 2009 | https://conductscience.org/library/papers/18929686 | PubMed |
| 9 | 28474732 | The Nephrotoxicity of Vancomycin. | Clin Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28474732 | PubMed |
| 10 | 29062271 | Aminoglycoside-Induced Cochleotoxicity: A Review. | Front Cell Neurosci | 2017 | https://conductscience.org/library/papers/29062271 | PubMed |
| 11 | 29914288 | Progressive Hearing Loss among Patients with Cystic Fibrosis and Parenteral Aminoglycoside Treatment. | Otolaryngol Head Neck Surg | 2018 | https://conductscience.org/library/papers/29914288 | PubMed |
| 12 | 2816859 | Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry. | Am J Dis Child | 1989 | https://conductscience.org/library/papers/2816859 | PubMed |
| 13 | 287328 | Inflammatory middle ear diseases in patients with cystic fibrosis. | Acta Otolaryngol Suppl | 1979 | https://conductscience.org/library/papers/287328 | PubMed |
| 14 | 10628715 | Histopathologic features of the temporal bone in patients with cystic fibrosis. | Arch Otolaryngol Head Neck Surg | 2000 | https://conductscience.org/library/papers/10628715 | PubMed |
| 15 | 29093664 | Towards the Prevention of Aminoglycoside-Related Hearing Loss. | Front Cell Neurosci | 2017 | https://conductscience.org/library/papers/29093664 | PubMed |
| 16 | 33661027 | Wideband Acoustic Reflex Growth in Adults With Cystic Fibrosis. | Am J Audiol | 2021 | https://conductscience.org/library/papers/33661027 | PubMed |
| 17 | 7054134 | Acoustic reflex after experimental lesions to inner and outer hair cells. | Hear Res | 1982 | https://conductscience.org/library/papers/7054134 | PubMed |
| 18 | 8836818 | Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis. | J Antimicrob Chemother | 1996 | https://conductscience.org/library/papers/8836818 | PubMed |
| 19 | 3885674 | Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin. | Acta Paediatr Scand | 1985 | https://conductscience.org/library/papers/3885674 | PubMed |
| 20 | 6637463 | Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. | Acta Paediatr Scand | 1983 | https://conductscience.org/library/papers/6637463 | PubMed |
| 21 | 17266591 | Aminoglycoside-induced ototoxicity. | Curr Pharm Des | 2007 | https://conductscience.org/library/papers/17266591 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42173068 | Speech-in-noise difficulties in aminoglycoside ototoxicity reflects combined afferent and efferent dysfunction. | Hear Res | 2026 | https://conductscience.org/library/papers/42173068 | PubMed |
| 40583133 | Wideband Middle-Ear Measures in Aminoglycoside-Exposed Adults with Cystic Fibrosis. | Ear Hear | 2025 | https://conductscience.org/library/papers/40583133 | PubMed |
| 40233985 | Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement project. | BMJ Open Qual | 2025 | https://conductscience.org/library/papers/40233985 | PubMed |
| 40161561 | What's New in Ototoxicity Management? | Perspect ASHA Spec Interest Groups | 2024 | https://conductscience.org/library/papers/40161561 | PubMed |
| 39935234 | Investigating the Potential Hearing Impairment and Ototoxicity in Children up to Six Years With Cystic Fibrosis After Aminoglycoside Exposure (PIANO-CF Extension). | Pediatr Pulmonol | 2025 | https://conductscience.org/library/papers/39935234 | PubMed |
| 39261989 | Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment. | Ear Hear | 2025 | https://conductscience.org/library/papers/39261989 | PubMed |
| 38333844 | Aminoglycoside-induced sensorineural hearing loss in pediatric cystic fibrosis patients: A retrospective cohort study. | Heliyon | 2024 | https://conductscience.org/library/papers/38333844 | PubMed |
| 37014872 | Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa. | PLoS One | 2023 | https://conductscience.org/library/papers/37014872 | PubMed |
| 36925655 | The Rise and Fall of Aural Acoustic Immittance Assessment Tools. | Semin Hear | 2023 | https://conductscience.org/library/papers/36925655 | PubMed |
| 36709582 | Brainstem auditory physiology in children with listening difficulties. | Hear Res | 2023 | https://conductscience.org/library/papers/36709582 | PubMed |
| 34917943 | Aminoglycoside- and glycopeptide-induced ototoxicity in children: a systematic review. | JAC Antimicrob Resist | 2021 | https://conductscience.org/library/papers/34917943 | PubMed |
| 34606329 | Ototoxicity and Noise Damage: From Preclinical Findings to Audiological Management. | Am J Audiol | 2021 | https://conductscience.org/library/papers/34606329 | PubMed |
| 34549989 | Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis. | Am J Audiol | 2021 | https://conductscience.org/library/papers/34549989 | PubMed |
| 34379758 | Pharmacokinetic modelling to predict risk of ototoxicity with intravenous tobramycin treatment in cystic fibrosis. | J Antimicrob Chemother | 2021 | https://conductscience.org/library/papers/34379758 | PubMed |
| 34261857 | Listening Difficulties in Children With Normal Audiograms: Relation to Hearing and Cognition. | Ear Hear | 2021 | https://conductscience.org/library/papers/34261857 | PubMed |
| 33661027 | Wideband Acoustic Reflex Growth in Adults With Cystic Fibrosis. | Am J Audiol | 2021 | https://conductscience.org/library/papers/33661027 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33465313
GET https://conductscience.org/api/papers/v1/33465313/references?page=2